GORE VIABAHN Endoprosthesis VBCR111002ARecalls & reported problems
W. L. Gore & Associates, Inc. · GORE VIABAHN Endoprosthesis 11mmx10cm 10Fr 120cmCath · Class 3 · Implant
All models of GORE VIABAHN Endoprosthesis (26)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00733132645886), received between Apr 30, 2024 and Oct 20, 2025 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Activation Failure” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Activation Failure2
- Difficult or Delayed Activation1
- Physical Resistance/Sticking1
- Premature Activation1
- Separation Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Failure of Implant1
- Insufficient Information1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryOct 20, 2025Difficult or Delayed Activation; Separation Problem; Difficult or Delayed Activation; Separation Problem
ON (B)(6) 2025, THE PATIENT UNDERWENT AN UNKNOWN ETIOLOGY WHERE A GORE® VIABAHN® ENDOPROSTHESIS (VIABAHN DEVICE) WAS INTENDED TO BE PLACED IN THE SUBCLAVIAN ARTERY. THE PHYSICIAN USED A 10FR TERUMO INTRODUCER SHEATH AND A 0.035" COOK MEDICAL ROADRUNNER® PC HYDROPHILIC WIRE GUIDE TO ADVANCE THE VIABAHN DEVICE TO THE TARGET TREATMENT AREA WITH NO RESISTANCE. DEPLOYMENT OF THE DEVICE WAS INITIATED; HOWEVER, THE VIABAHN DEVICE FAILED TO DEPLOY. IT IS UNCLEAR HOW MUCH OF THE DEPLOYMENT LINE WAS PULLED PRIOR TO THE ATTEMPT TO WITHDRAW THE CONSTRAINED DEVICE. DURING THE WITHDRAWAL OF THE VIABAHN DEVICE IN TANDEM WITH THE SHEATH, RESISTANCE WAS ENCOUNTERED. SUBSEQUENTLY, THE DEVICE UNINTENTIONALLY DISLODGED WITHIN THE PATIENT¿S UPPER ARM. A SURGICAL CUTDOWN WAS REQUIRED TO RETRIEVE THE DEPLOYED VIABAHN DEVICE. NO PRIOR ATTEMPTS WERE MADE TO RETRIEVE THE DISLODGED ENDOPROSTHESIS THROUGH NON-SURGICAL MEANS. THE PROCEDURE WAS COMPLETED BY SUTURING THE PATIENT¿S ARTERY. NO ADDITIONAL ADVERSE EVENTS WERE REPORTED. THE PHYSICIAN NOTED THAT THERE WERE NO INDICATIONS OF TORTUOUS ANATOMY OR CALCIFICATION, AND THE ROOT CAUSE OF THE DEPLOYMENT ISSUE REMAINS UNDETERMINED.
Patient problems: Failure of Implant
MAUDE report 23337702 ↗MalfunctionNov 26, 2024Activation Failure; Activation Failure
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2024, A GORE® VIABAHN® ENDOPROSTHESIS (VSX DEVICE) WAS INTENDED FOR USE IN THE CEPHALIC ARCH DURING TREATMENT OF STENOSIS. IT WAS REPORTED THAT THE STENOSIS WAS PRE-DILATED WITH A 4 MM CONQUEST BALLOON. THE PHYSICIAN THEN ADVANCED THE VSX DEVICE THROUGH A 10FR TERUMO INTRODUCER SHEATH, OVER A 0.035" STIFF ROAD RUNNER GUIDEWIRE AND ACROSS THE LESION. REPORTEDLY, AFTER DEPLOYMENT WAS INITIATED THE DEPLOYMENT LINE GOT STUCK. THE PHYSICIAN ATTEMPTED TO PULL THE DEPLOYMENT LINE A FEW MORE TIMES WITH NO SUCCESS AND WITH NO DEVICE EXPANSION THE VSX DEVICE WAS REMOVED. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20778904 ↗MalfunctionAug 8, 2024Premature Activation; Premature Activation
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2024, AN 11MM X 10CM GORE® VIABAHN® ENDOPROSTHESIS (VSX DEVICE) WAS INTENDED FOR USE IN THE UPPER ARM DURING TREATMENT OF STENOSIS IN A DIALYSIS ACCESS GRAFT (MANUFACTURER UNKNOWN). AFTER AN ANGIOPLASTY WAS PERFORMED, THE PHYSICIAN ATTEMPTED TO ADVANCE THE VSX DEVICE. HOWEVER, THE PHYSICIAN MET RESISTANCE WHILE ADVANCING THE VSX DEVICE THROUGH THE STENOSIS AND THE CATHETER STARTED KINKING. WITH THE INABILITY TO ADVANCE THE VSX DEVICE THROUGH THE STENOSIS, THE PHYSICIAN ATTEMPTED TO REMOVE THE VSX DEVICE. HOWEVER, THE VSX DEVICE HAD DISTAL EXPANSION, AND THE PHYSICIAN WAS UNABLE TO REMOVE THE VSX DEVICE THROUGH THE 10FR CORDIS BRITE TIP INTRODUCER SHEATH. THE PHYSICIAN REMOVED THE 0.035" TERUMO GLIDEWIRE ADVANTAGE, INTRODUCER SHEATH AND VSX DEVICE IN TANDEM. A 13MM X 10CM VSX DEVICE WAS SUCCESSFULLY DELIVERED TO COMPLETE THE PROCEDURE. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19941929 ↗MalfunctionApr 30, 2024Activation Failure; Physical Resistance/Sticking; Activation Failure; Physical Resistance/Sticking
THE FOLLOWING WAS REPORTED TO GORE: ON AN UNKNOWN DATE, THE PATIENT UNDERWENT A PROCEDURE FOR A AV FISTULA IN THE UPPER ARM USING A GORE® VIABAHN® ENDOPROSTHESIS (VIABAHN DEVICE). IT WAS REPORTED THAT THE PHYSICIAN WAS UNABLE TO DEPLOY THE VIABAHN DEVICE INSIDE THE BODY AS THE DEPLOYMENT LINE WOULD NOT DETACH FROM THE STENT.
Patient problems: Insufficient Information
MAUDE report 19218273 ↗
Other Stent, Superficial Femoral Artery devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page